Constructed wetlands are increasingly proposed as nature-based solutions for decentralized wastewater treatment and agricultural water reuse; however, integrated evaluations of contaminant removal and associated environmental and human health risks across enhanced wetland configurations remain limited. This study evaluated twelve target analytical parameters representing pharmaceuticals and industrial micropollutants in six pilot-scale treatment configurations assembled from horizontal-flow and vertical-flow wetland units operated under aerated and non-aerated conditions. The aerated vertical-flow followed by the aerated horizontal-flow configuration achieved the highest removal for several compounds, including clarithromycin (70.6%), benzotriazole (69.8%), diclofenac (62.2%), venlafaxine (61.2%), and metoprolol (47.6%), whereas carbamazepine and sartans remained poorly removed (<15.0%). Screening-level environmental risk assessment identified diclofenac, clarithromycin, and citalopram as the principal ecological risk drivers, with risk quotients remaining above 1.0 after treatment in several configurations. In contrast, the modelled lettuce-irrigation assessment yielded individual hazard quotients below 0.1. The combined analysis therefore revealed a key risk-management contrast: configurations that improved contaminant attenuation reduced both cumulative risk metrics, but ecological concern could persist even when modelled human health risk remained low.
Khoshbin, S., Mancuso, G., Testaquatra, G., Drei, P., Annesi, G., Lavrnić, S., et al. (2026). Treatment of contaminants of emerging concern by constructed wetlands: removal and risk assessment under discharge and agricultural irrigation scenarios. WATER RESEARCH. X, 33, 1-13 [10.1016/j.wroa.2026.100632].
Treatment of contaminants of emerging concern by constructed wetlands: removal and risk assessment under discharge and agricultural irrigation scenarios
Khoshbin, Samira;Mancuso, Giuseppe
;Testaquatra, Gabriele;Drei, Pietro;Annesi, Gianvito;Lavrnić, Stevo;Toscano, Attilio
2026
Abstract
Constructed wetlands are increasingly proposed as nature-based solutions for decentralized wastewater treatment and agricultural water reuse; however, integrated evaluations of contaminant removal and associated environmental and human health risks across enhanced wetland configurations remain limited. This study evaluated twelve target analytical parameters representing pharmaceuticals and industrial micropollutants in six pilot-scale treatment configurations assembled from horizontal-flow and vertical-flow wetland units operated under aerated and non-aerated conditions. The aerated vertical-flow followed by the aerated horizontal-flow configuration achieved the highest removal for several compounds, including clarithromycin (70.6%), benzotriazole (69.8%), diclofenac (62.2%), venlafaxine (61.2%), and metoprolol (47.6%), whereas carbamazepine and sartans remained poorly removed (<15.0%). Screening-level environmental risk assessment identified diclofenac, clarithromycin, and citalopram as the principal ecological risk drivers, with risk quotients remaining above 1.0 after treatment in several configurations. In contrast, the modelled lettuce-irrigation assessment yielded individual hazard quotients below 0.1. The combined analysis therefore revealed a key risk-management contrast: configurations that improved contaminant attenuation reduced both cumulative risk metrics, but ecological concern could persist even when modelled human health risk remained low.| File | Dimensione | Formato | |
|---|---|---|---|
|
2026_Treatment of contaminants of emerging concern.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale / Version Of Record
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione
4.76 MB
Formato
Adobe PDF
|
4.76 MB | Adobe PDF | Visualizza/Apri |
|
1-s2.0-S2589914726001593-mmc1.docx
accesso aperto
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione
996.99 kB
Formato
Microsoft Word XML
|
996.99 kB | Microsoft Word XML | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



